The class of chemical compounds known as Ypk1 inhibitors encompasses a diverse array of molecules that share a common function: the disruption of Ypk1 kinase activity through targeted interactions with its structural and functional components. Ypk1, a protein kinase present in various eukaryotic organisms, plays a pivotal role in regulating cellular processes such as membrane trafficking, protein secretion, and stress responses. Its intricate involvement in vital cellular pathways has made it an attractive target for scientific exploration. Ypk1 inhibitors exert their effects by specifically modulating the enzymatic activity of Ypk1, which is vital for its phosphorylation of downstream substrates. Mechanistically, these inhibitors often operate by impeding the key steps in Ypk1 activation and signaling. Some compounds, such as Perifosine and Fingolimod, act by interfering with Ypk1's localization. By binding to specific domains or motifs that facilitate membrane attachment, these inhibitors prevent Ypk1 from reaching its site of action and interacting with its substrates.
Other Ypk1 inhibitors, like PF-543 and Torin 1, target upstream regulators of Ypk1, such as mTORC1. By influencing these regulatory pathways, they indirectly modulate Ypk1 activity. Additionally, some Ypk1 inhibitors, like Halofuginone and Cerulenin, function by directly impacting the enzymatic activity of Ypk1, either through competitive inhibition or by affecting its substrate recognition. The wide range of mechanisms by which Ypk1 inhibitors exert their effects reflects the complex nature of Ypk1's role in cellular signaling. The development and study of these inhibitors have not only provided insights into the molecular mechanisms of Ypk1 but have also contributed to a deeper understanding of the broader pathways in which Ypk1 participates. Researchers continue to investigate the structure-activity relationships of these compounds to enhance their specificity and potency, shedding light on the intricate regulation of Ypk1 and its significance in cellular homeostasis. As our understanding of Ypk1 inhibitors advances, so does our ability to dissect the nuances of Ypk1-mediated signaling and its implications for cellular function.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
Inhibits Ypk1 by disrupting its interaction with its activator, sphingosine kinase, thereby preventing downstream signaling cascades. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Binds to the pleckstrin homology (PH) domain of Ypk1, preventing its membrane localization and subsequent activation. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
Phosphorylated by Ypk1, it acts as a functional antagonist by binding to sphingosine-1-phosphate receptors, reducing Ypk1 activity. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Acts as a competitive substrate for Ypk1, sequestering it and preventing its interaction with other substrates. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Inhibits Ypk1 by interfering with its substrate recognition and kinase activity, leading to downstream effects on translation initiation. | ||||||
PF-543 | 1415562-82-1 | sc-507507 | 10 mg | $210.00 | ||
Selectively inhibits Ypk1 and Ypk2 by binding to their ATP-binding sites, blocking phosphorylation of downstream substrates. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Reduces Ypk1 activity by inhibiting fatty acid synthesis, an important pathway regulated by Ypk1. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor that targets Ypk1 among other kinases, disrupting various signaling pathways. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Blocks Ypk1 by inhibiting the mTOR complex 1 (mTORC1), a key upstream regulator of Ypk1 signaling. | ||||||
AZD2014 | 1009298-59-2 | sc-364420 | 5 mg | $303.00 | 2 | |
Inhibits Ypk1 by targeting mTORC1, an upstream regulator of Ypk1 signaling, thus suppressing its activation. | ||||||